Skip to content
HowShorted

Bio-Path Holdings, Inc. short interest in 2022

In 2022, Bio-Path Holdings, Inc.'s disclosed short interest ran from 1.72% of shares outstanding on 14 Jan 2022 to 0.36% on 30 Dec 2022, a change of -1.36 percentage points. The year's high was 1.85% on 31 Jan 2022 and its low 0.36% on 30 Dec 2022, averaging 0.94% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.53 days on 15 Feb 2022. Full history: Bio-Path Holdings, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for Bio-Path Holdings, Inc. in 2022

2022 in figures

Start of year
1.72% (14 Jan 2022)
End of year
0.36% (30 Dec 2022)
Change
-1.36 pp
High
1.85% (31 Jan 2022)
Low
0.36% (30 Dec 2022)
Average
0.94%
Highest days to cover
3.53 (15 Feb 2022)
SEC filings marked
8

Every report in 2022

Bio-Path Holdings, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20221.72%2.66
31 Jan 20221.85%2.54
15 Feb 20221.54%3.53
28 Feb 20221.54%3.23
15 Mar 20221.23%2.8110-K filed, results (8-K)
31 Mar 20220.84%1.91
14 Apr 20221.34%1.00
29 Apr 20220.94%1.32
13 May 20221.40%1.88
31 May 20221.15%2.5610-Q filed, results (8-K)
15 Jun 20221.24%3.02
30 Jun 20220.86%1.00
15 Jul 20220.74%2.17
29 Jul 20220.73%1.91
15 Aug 20220.67%1.5510-Q filed
31 Aug 20220.60%3.03results (8-K)
15 Sep 20220.52%3.13
30 Sep 20220.48%1.39
14 Oct 20220.48%3.24
31 Oct 20220.48%2.94
15 Nov 20220.41%1.0010-Q filed, results (8-K)
15 Dec 20220.46%1.00
30 Dec 20220.36%1.00

See also: Bio-Path Holdings, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.